Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus
Open accessAbstract
Background & aims Experimental evidence indicates that proton pump inhibitors (PPIs), nonsteroidal anti-inflammatory drugs (NSAIDs)/aspirin, and statins can protect patients with Barrett's esophagus (BE) from developing neoplasias. However, only limited data are available on chemoprevention in patients with BE.Methods A retrospective observational study was performed using data from patients with documented BE. Prescription information was collected from pharmacy records. Cox regression analyses were performed to examine the association between prescriptions for PPIs, NSAIDs/aspirin, or statins and the risk of developing esophageal dysplasia or adenocarcinoma during follow-up (from 1982 to 2005).Results We examined 344 patients diagnosed with BE (mean age 61 years, 90.4% Caucasian, 94.2% male). After BE diagnosis, 67.2% of the patients were prescribed PPIs for a mean duration of 5.1 years; 49.1% were prescribed NSAIDs for a mean duration of 3.6 years, and 25.3% were prescribed statins for a mean duration of 2.8 years. During 2620 patient-years, high grade dysplasia or esophageal adenocarcinoma developed in 33 patients. PPI treatment after BE diagnosis was associated with a reduced risk of high grade dysplasia or cancer; this association persisted after adjustment for gender, age, and the length of BE. NSAID and/or aspirin therapy were associated with a nonsignificant trend toward lower incidence of high grade dysplasia or esophageal cancer.Conclusions PPI therapy reduces the risk of neoplasms in patients with BE. NSAIDs/aspirin appear to reduce cancer risk whereas statin use is not significantly associated with the risk of neoplasia in patients with BE.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Long-term PPI use significantly decreases the risk of progression to high-grade dysplasia and EAC in patients with non-dysplastic BE.
“because their long-term use significantly decreases the risk of the progression to high-grade dysplasia and EAC[50-52]”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,012 · see citing works
Wilkinson, E. (2002) · Nature Cell Biology · doi:10.1016/s1470-2045(02)00737-4 · Cited by 951 · see citing works
Corley, D. A., Kerlikowske, K. M., Verma, R., & Buffler, P. A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50008 · Cited by 522 · see citing works
Chow, W.-H. (1995) · JAMA · doi:10.1001/jama.1995.03530060048032 · Cited by 365 · see citing works
Buttar, N. S., Wang, K. K., Leontovich, O. N., Westcott, J. Y., Pacifico, R. J., Anderson, M. A., Krishnadath, K. K., Lutzke, L. S., & Burgart, L. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32371 · Cited by 346 · see citing works
Proton Pump Inhibitors Are Associated with Reduced Incidence of Dysplasia in Barrett's Esophagus
El‐Serag, H. B., Aguirre, T. V., Davis, S., Kuebeler, M. K., Bhattacharyya, A., & Sampliner, R. E. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30228.x · Cited by 329 · see citing works
Self-citation3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of Cancer
Blais, L., Desgagné, A., & LeLorier, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2363 · Cited by 326 · see citing works
Cyclooxygenase-2 Expression in The Barrettʼs Metaplasia–Dysplasia–Adenocarcinoma Sequence
Morris, C. D., Armstrong, G. R., Bigley, G., Green, H. E., & Attwood, S. E. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03599.x · Cited by 250 · see citing works
Vaughan, T. L., Dong, L. M., Blount, P. L., Ayub, K., Odze, R. D., Sanchez, C. A., Rabinovitch, P. S., & Reid, B. J. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70431-9 · Cited by 216 · see citing works
Proton‐pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus
Hillman, L. C., Chiragakis, L., Kaye, G., Clarke, A. C., & Shadbolt, B. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05991.x · Cited by 194 · see citing works
Secondary Chemoprevention of Barrett's Esophagus With Celecoxib: Results of a Randomized Trial
Heath, E. I., Canto, M. I., Piantadosi, S., Montgomery, E. A., Weinstein, W. M., Herman, J. G., Dannenberg, A. J., Yang, V. W., Shar, A. O., Hawk, E. T., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk112 · Cited by 178 · see citing works
Karp, I., Behlouli, H., LeLorier, J., & Pilote, L. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.12.011 · Cited by 152 · see citing works
Statins Inhibit Proliferation and Induce Apoptosis in Barrett's Esophageal Adenocarcinoma Cells
Ogunwobi, O. O., & Beales, I. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01773.x · Cited by 149 · see citing works
Cooper, B. T., Chapman, W., Neumann, C. S., & Gearty, J. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02825.x · Cited by 109 · see citing works
Pera, M. (2003) · World Journal of Surgery · doi:10.1007/s00268-003-7052-2 · Cited by 96 · see citing works
Aspirin, Nonsteroidal Anti-inflammatory Drugs, and the Risks of Cancers of the Esophagus
Sadeghi, S., Bain, C. J., Pandeya, N., Webb, P. M., Green, A. C., Whiteman, D. C., & Study, F. T. A. C. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2852 · Cited by 79 · see citing works
Barrett's Esophagus and Medications that Relax the Lower Esophageal Sphincter
Corley, D. A., Levin, T. R., Habel, L. A., & Buffler, P. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00539.x · Cited by 54 · see citing works
Tsibouris, P., Hendrickse, M. T., & Isaacs, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02150.x · Cited by 28 · see citing works
Barrett's oesophagus and proton pump inhibitors: a pathological perspective
Shepherd, N. A. (2000) · Gut · doi:10.1136/gut.46.2.147 · Cited by 16 · see citing works
Flagged first, then by citations
1 of the 20 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [19]Ogunwobi OO Beales IL Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells Am J Gastroenterol 2008 April 103 4 825 37 18371146
Cited by
Sorted by citations
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
Shaheen, N. J., Falk, G. W., Iyer, P. G., & Gerson, L. B. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.322 · Cited by 1,498 · see citing works
Fitzgerald, R. C., di Pietro, M., Ragunath, K., Ang, Y. S., Kang, J.-Y., Watson, P. J., Trudgill, N. J., Patel, P., Kaye, P., Sanders, S., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-305372 · Cited by 1,344 · see citing works
Rustgi, A. K., & El‐Serag, H. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314530 · Cited by 1,318 · see citing works
Self-citationSmyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,063 · see citing works
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Spechler, S., Sharma, P., Souza, R., Inadomi, J., & Shaheen, N. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.031 · Cited by 981 · see citing works
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
Desai, T. K., Krishnan, K., Samala, N. R., Singh, J., Cluley, J. D., Perla, S., & Howden, C. W. (2011) · Gut · doi:10.1136/gutjnl-2011-300730 · Cited by 606 · see citing works
Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?
Pohl, H., Sirovich, B., & Welch, H. G. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0012 · Cited by 420 · see citing works
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis
Reid, B. J., Li, X., Galipeau, P. C., & Vaughan, T. L. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2773 · Cited by 377 · see citing works
Recent developments in esophageal adenocarcinoma
Lagergren, J., & Lagergren, P. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21185 · Cited by 309 · see citing works
Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G., & El-Serag, H. B. (2014) · Gut · doi:10.1136/gutjnl-2013-305997 · Cited by 298 · see citing works
Self-citationProton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258 · see citing works
Gastrointestinal cancers in China, the USA, and Europe
Xie, Y., Shi, L., He, X., & Luo, Y. (2021) · Gastroenterology report · doi:10.1093/gastro/goab010 · Cited by 241 · see citing works
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. E. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 234 · see citing works
Wani, S. B., Falk, G. W., Hall, M., Gaddam, S., Wang, A., Gupta, N., Singh, M., Singh, V., Chuang, K., Boolchand, V., et al. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.11.008 · Cited by 231 · see citing works
Self-citationSafety of Proton Pump Inhibitor Exposure
Yang, Y., & Metz, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.023 · Cited by 215 · see citing works
Kastelein, F., Spaander, M. C. W., Steyerberg, E. W., Biermann, K., Valkhoff, V. E., Kuipers, E. J., & Bruno, M. J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.11.014 · Cited by 201 · see citing works
McQuaid, K., Laine, L., Fennerty, M. B., Souza, R. F., & Spechler, S. J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04709.x · Cited by 187 · see citing works
Risk Factors in the Development of Esophageal Adenocarcinoma
Pohl, H., Wrobel, K., Bojarski, C., Voderholzer, W. A., Sonnenberg, A., Rösch, T., & Baumgart, D. C. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.387 · Cited by 185 · see citing works
Nguyen, D. M., Richardson, P. A., & El‐Serag, H. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.045 · Cited by 184 · see citing works
Self-citationSingh, S., Singh, A. G., Singh, P. P., Murad, M. H., & Iyer, P. G. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.036 · Cited by 178 · see citing works
Bennett, C., Moayyedi, P., Corley, D. A., Caestecker, J. S. D., Falck-Ytter, Y. T., Falk, G. W., Vakil, N. B., Sanders, S., Vieth, M. W., Inadomi, J. M., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.55 · Cited by 170 · see citing works
Self-citation2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease
Jung, H., Tae, C. H., Song, K. H., Kang, S. J., Park, J. K., Gong, E. J., Shin, J. E., Lim, H. C., Lee, S. K., Jung, D. H., et al. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21077 · Cited by 163 · see citing works
Liao, L. M., Vaughan, T. L., Corley, D. A., Cook, M. B., Casson, A. G., Kamangar, F., Abnet, C. C., Risch, H. A., Giffen, C. A., Freedman, N. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.11.019 · Cited by 160 · see citing works
Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis
Krishnamoorthi, R., Singh, S., Ragunathan, K., Visrodia, K., Wang, K. K., Katzka, D. A., & Iyer, P. G. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.11.044 · Cited by 149 · see citing works
Kastelein, F., Spaander, M. C. W., Biermann, K., Steyerberg, E. W., Kuipers, E. J., & Bruno, M. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.036 · Cited by 135 · see citing works
Whiteman, D. C., Appleyard, M. N., Bahin, F. F., Bobryshev, Y. V., Bourke, M. J., Brown, I., Chung, A., Clouston, A. D., Dickins, E., Emery, J. D., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12913 · Cited by 126 · see citing works
Hvid‐Jensen, F., Pedersen, L. H., Funch-Jensen, P. M., & Drewes, A. M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12693 · Cited by 102 · see citing works
Hu, Q., Sun, T.-T., Hong, J., Fang, J., Xiong, H., & Meltzer, S. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169691 · Cited by 89 · see citing works
Zhang, S., Xq, Z., Ding, X.-W., Yang, R.-K., Huang, S.-L., Kastelein, F., Bruno, M. J., Yu, X., Zhou, D.-Q., & Xp, Z. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.127 · Cited by 77 · see citing works
Barrett’s esophagus and esophageal cancer: An overview
Conteduca, V., Sansonno, D. E., Ingravallo, G., Marangi, S., Russi, S., Lauletta, G., & Dammacco, F. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1481 · Cited by 70 · see citing works
Singh, S., Devanna, S., Varayil, J. E., Murad, M. H., & Iyer, P. G. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-101 · Cited by 67 · see citing works
The esophagitis to adenocarcinoma sequence; the role of inflammation
Kavanagh, M. E., O’Sullivan, K. E., O’Hanlon, C., O'Sullivan, J. N., Lysaght, J., & Reynolds, J. V. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.017 · Cited by 66 · see citing works
Prescribing Proton Pump Inhibitors
Vakil, N. B. (2012) · Drugs · doi:10.2165/11599320-000000000-00000 · Cited by 64 · see citing works
Falk, G. W., Buttar, N. S., Foster, N. R., Ziegler, K. L. A., DeMars, C. J., Romero, Y., Marcon, N. E., Schnell, T. G., Corley, D. A., Sharma, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.044 · Cited by 63 · see citing works
Esophageal cancer: The latest on chemoprevention and state of the art therapies
Bras, G. F. L., Farooq, M. H., Falk, G. W., & Andl, C. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.021 · Cited by 62 · see citing works
Pathophysiology and treatment of Barrett’s esophagus
Oh, D. S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i30.3762 · Cited by 60 · see citing works
Wenker, T. N., Duan, Z., Naik, A. D., Kramer, J. R., & El‐Serag, H. B. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.009 · Cited by 56 · see citing works
Self-citationUse of Statin Medications and Risk of Esophageal Adenocarcinoma in Persons with Barrett's Esophagus
Kantor, E. D., Onstad, L., Blount, P. L., Reid, B. J., & Vaughan, T. L. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1014 · Cited by 52 · see citing works
Beales, I., Vardi, I., & Dearman, L. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283543f01 · Cited by 50 · see citing works
Alexandre, L., Clark, A., Bhutta, H. Y., Holt, S., Lewis, M. P., & Hart, A. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.11.046 · Cited by 49 · see citing works
The Role of Proton Pump Inhibitors in the Management of Upper Gastrointestinal Disorders.
Khan, M. A., & Howden, C. W. (2018) · Europe PMC (PubMed Central) · Cited by 49 · see citing works
Barrett’s Esophagus: A Review of the Literature
Gilbert, E. W., Luna, R. A., Harrison, V. L., & Hunter, J. G. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1485-y · Cited by 48 · see citing works
Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition
Beales, I. L. P., Hensley, A., & Loke, Y. K. (2013) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v4.i3.69 · Cited by 45 · see citing works
Prevention Strategies for Esophageal Cancer—An Expert Review
Marabotto, E., Pellegatta, G., Sheijani, A. D., Ziola, S., Zentilin, P., Demarzo, M. G., Giannini, E. G., Ghisa, M., Barberio, B., Scarpa, M., et al. (2021) · Cancers · doi:10.3390/cancers13092183 · Cited by 45 · see citing works
Thomas, T. R., Loke, Y. K., & Beales, I. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-9983-0 · Cited by 43 · see citing works
Chen, Y., Sun, C., Wu, Y., Chen, X., Kailas, S., Karadsheh, Z., Li, G., Guo, Z., Yang, H., Hu, L., et al. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03544-3 · Cited by 40 · see citing works
Tan, M. C., El‐Serag, H. B., Yu, X., & Thrift, A. P. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14895 · Cited by 36 · see citing works
Self-citationKlaver, E., Gonzalez, A. B., Mostafavi, N. S., Mallant–Hent, R. C., Duits, L. C., Baak, B. C., Böhmer, C. J. M., van Oijen, A. H. A. M., Naber, A. H. J., Scholten, P., et al. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12114 · Cited by 35 · see citing works
Adil, M. T., Al‐Taan, O., Rashid, F., Munasinghe, A., Jain, V., Whitelaw, D., Jambulingam, P. S., & Mahawar, K. K. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04083-0 · Cited by 34 · see citing works
Younes, M., Brown, K., Lauwers, G. Y., Ergun, G. A., Meriano, F. V., Schmulen, A. C., Barroso, A. O., & Ertan, A. (2017) · Histopathology · doi:10.1111/his.13193 · Cited by 33 · see citing works
Joo, M. K., Park, J., & Chun, H. J. (2017) · Digestive Diseases · doi:10.1159/000480149 · Cited by 30 · see citing works
Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma
Alexandre, L., Clark, A., Cheong, E., Lewis, M. P., & Hart, A. R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05194.x · Cited by 30 · see citing works
Current Status and Future Perspectives on the Etiology of Esophageal Adenocarcinoma
Thrift, A. P., Pandeya, N., & Whiteman, D. C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00011 · Cited by 30 · see citing works
Risk factors and chemoprevention in Barrett's esophagus – an update
Winberg, H., Lindblad, M., Lagergren, J., & Dahlstrand, H. M. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2012.667145 · Cited by 26 · see citing works
The Effect of Proton Pump Inhibitors on Barrett’s Esophagus
Dunbar, K. B., Souza, R. F., & Spechler, S. J. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.02.010 · Cited by 26 · see citing works
Wang, F., Lv, Z. S., & Fu, Y. (2010) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01153.x · Cited by 26 · see citing works
Screening and Preventive Strategies in Esophagogastric Cancer
Zakko, L., Lutzke, L. S., & Wang, K. K. (2017) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2016.10.004 · Cited by 25 · see citing works
Beales, I., Vardi, I., Dearman, L., & Broughton, T. (2012) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2012.01412.x · Cited by 25 · see citing works
Nonsteroidal Anti-inflammatory Drugs and Inflammatory Bowel Disease
Habib, I., Mazulis, A., Roginsky, G., & Ehrenpreis, E. D. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000165 · Cited by 25 · see citing works
Targeting the Microenvironment in Esophageal Cancer
Wang, L., Han, H., Wang, Z., Shi, L., Yang, M., & Qin, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.684966 · Cited by 25 · see citing works
Kastelein, F., Spaander, M. C. W., Biermann, K., Vucelic, B. N., Kuipers, E. J., & Bruno, M. J. (2011) · Digestive Diseases · doi:10.1159/000331513 · Cited by 24 · see citing works
The relationship among proton pump inhibitors, bone disease and fracture
Targownik, L. E., & Leslie, W. D. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.586628 · Cited by 23 · see citing works
Molecular Biology and Clinical Management of Esophageal Adenocarcinoma
Li, S., Hoefnagel, S. J. M., & Krishnadath, K. K. (2023) · Cancers · doi:10.3390/cancers15225410 · Cited by 23 · see citing works
Effect of medical and surgical treatment of Barrett’s metaplasia
Wassenaar, E. B. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i30.3773 · Cited by 23 · see citing works
Does Barrett's Esophagus Regress after Surgery (or Proton Pump Inhibitors)
Spechler, S. J. (2014) · Digestive Diseases · doi:10.1159/000357184 · Cited by 22 · see citing works
Aspirin chemoprevention of gastrointestinal cancer in the next decade. A review of the evidence
Jankowska, H., Hooper, P., & Jankowski, J. A. (2010) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.981 · Cited by 22 · see citing works
Diagnosis and Management of Barrett's Esophagus
Nelsen, E. M., Hawes, R. H., & Iyer, P. G. (2012) · Surgical Clinics of North America · doi:10.1016/j.suc.2012.07.009 · Cited by 22 · see citing works
Thanan, R., Ma, N., Iijima, K., Abe, Y., Koike, T., Shimosegawa, T., Pinlaor, S., Hiraku, Y., Oikawa, S., Murata, M., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.152 · Cited by 22 · see citing works
Low Risk of Progression of Barrett’s Esophagus to Neoplasia in Women
Allen, J. E., Desai, M., Roumans, C. A. M., Vennalaganti, S., Vennalaganti, P. R., Bansal, A. K., Falk, G. W., Lieberman, D. A., Sampliner, R. E., Thota, P. N., et al. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001362 · Cited by 21 · see citing works
Self-citationProton pump inhibitors and risk of gastrointestinal cancer: A meta‑analysis of cohort studies
Tran, T. M., Myung, S., & Trinh, T. T. (2023) · Oncology Letters · doi:10.3892/ol.2023.14161 · Cited by 20 · see citing works
Neu erkannte Nebenwirkungen von Protonenpumpeninhibitoren
von Rahden, B. H. A., Scheurlen, M., Filser, J., Stein, H. J., & Ct, G. (2011) · Der Chirurg · doi:10.1007/s00104-011-2173-x · Cited by 19 · see citing works
Cooper, S. C., Menon, S., Nightingale, P., & Trudgill, N. J. (2014) · United European Gastroenterology Journal · doi:10.1177/2050640614523596 · Cited by 19 · see citing works
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease
Jung, H.-K., Tae, C. H., Song, K. H., Kang, S. J., Park, J. K., Gong, E. J., Shin, J. E., Lim, H. C., Lee, S. K., Jung, D. H., et al. (2022) · Korean Journal of Medicine · doi:10.3904/kjm.2022.97.2.70 · Cited by 18 · see citing works
Screening and Risk Stratification for Barrett's Esophagus
di Pietro, M., & Fitzgerald, R. C. (2013) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.11.006 · Cited by 17 · see citing works
Barrett's esophagus: What do we need to know?
Mohy‐ud‐din, N., Krill, T. S., Shah, A. R., Chatila, A. T., Singh, S., Bilal, M., & Parupudi, S. V. J. (2019) · Disease-a-Month · doi:10.1016/j.disamonth.2019.02.003 · Cited by 17 · see citing works
Thrift, A. P. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.03.028 · Cited by 16 · see citing works
Chemoprevention of esophageal adenocarcinoma
Snider, E. J., Kaz, A. M., Inadomi, J. M., & Grady, W. M. (2020) · Gastroenterology report · doi:10.1093/gastro/goaa040 · Cited by 15 · see citing works
Ko, M. T., Thomas, T. R., Holden, E., Beales, I., & Alexandre, L. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.07.041 · Cited by 18 · see citing works
Gastrointestinal pharmacology: practical tips for the esophagologist
Scarpignato, C., Sloan, J. A., Wang, D. H., & Hunt, R. H. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14447 · Cited by 14 · see citing works
Chemoprevention in Barrett's Esophagus: A Pill a Day?
Jankowski, J. A., & Hooper, P. A. (2010) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2010.09.005 · Cited by 13 · see citing works
Scholl, S., Dellon, E. S., & Shaheen, N. J. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.409 · Cited by 12 · see citing works
Rajendra, S., & Sharma, P. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12446668 · Cited by 11 · see citing works
Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions
Konda, V. J. A., & Dalal (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s23425 · Cited by 10 · see citing works
Yao, H., Wang, L., Li, H., Xu, S., Bai, Z., Wu, Y., Chen, H., Goyal, H., & Qi, X. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2008909 · Cited by 10 · see citing works
Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett’s esophagus
Tsibouris, P. (2014) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v5.i1.27 · Cited by 9 · see citing works
Neu erkannte Nebenwirkungen von Protonenpumpeninhibitoren: Argumente Pro Fundoplicatio bei GERD?
von Rahden, B. H. A., Scheurlen, M., Filser, J., Stein, H. J., & Germer, C.-T. (2012) · Der Chirurg · Cited by 9 · see citing works
Aspirin Use is Associated with Lower Risk of Barrett's Esophagus in Women
Jovani, M., Cao, Y., Feskanich, D., Hur, C., Jacobson, B. C., & Chan, A. T. (2017) · Gastroenterology · doi:10.1016/s0016-5085(17)30692-3 · Cited by 9 · see citing works
Huang, J., Liu, H., Sun, T., Fang, J., Wang, J., & Xiong, H. (2019) · Clinical Science · doi:10.1042/cs20180828 · Cited by 9 · see citing works
Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma
Rajendra, S., & Sharma, P. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.01.003 · Cited by 8 · see citing works
Evaluation and Management of Premalignant Conditions of the Esophagus
Ramai, D., Lai, J., Ofori, E., Linn, S., & Reddy, M. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001247 · Cited by 8 · see citing works
Peura, D. A., & Wilcox, C. M. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.01.2728 · Cited by 8 · see citing works
Goldberg, A., Gerkin, R. D., & Young, M. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3569-0 · Cited by 8 · see citing works
Statins as Potential Therapeutics for Esophageal Cancer
Hassanabad, A. F., & Wong, J. V. S. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00648-4 · Cited by 8 · see citing works
Rajendra, S., & Sharma, P. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0012-0 · Cited by 8 · see citing works
Kasiri, K., Sherwin, C. M. T., Rostamian, S., & Heidari-Soureshjani, S. (2023) · Current Therapeutic Research · doi:10.1016/j.curtheres.2023.100692 · Cited by 8 · see citing works
Chemoprevention of Gastrointestinal Neoplasia
Half, E., & Arber, N. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0320-x · Cited by 8 · see citing works
Statin use and the risk of esophageal cancer: a population-based case-control study
Chan, T., Chiu, H., Wu, C., Lin, C., & Yang, C. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.778241 · Cited by 8 · see citing works
Data to Guide the “Test and Treat Era” of Hepatitis C
Ward, J. W., Rein, D. B., & Smith, B. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.027 · Cited by 8 · see citing works
Li, L., Cao, Z., Zhang, C., Geng, X., Wang, J., Pan, W., & Jing, J. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-3362 · Cited by 7 · see citing works
Low grade dysplasia in Barrett’s esophagus: Should we worry?
Jagadesham, V. P., & Kelty, C. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i2.91 · Cited by 7 · see citing works
- Authors
- Nguyen, D. M., El-Serag, H. B., Henderson, L., Stein, D., Bhattacharyya, A., & Sampliner, R. E.
- Affiliations
- Michael E. DeBakey VA Medical Center (US)
- University of Arizona (US)
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 7
- Issue
- 12
- Pages
- 1299-1304
- ISSN
- 1542-3565 (ISSN-L)
- PMC
- PMC2789910
- OpenAlex
- W2071302779
- Cited by
- 159
- References
- 20
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 4 · 2021: 13 · 2020: 4 · 2019: 8 · 2018: 4 · 2017: 9 · 2016: 4 · 2015: 15 · 2014: 15 · 2013: 17 · 2012: 25
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Gastroenterology and Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA116845)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK078154, DK 563338)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
- Health Sciences › Medicine › Surgery › Esophageal and GI Pathology
- Keywords
- Barrett's esophagus, proton pump inhibitors, nonsteroidal anti-inflammatory drugs, aspirin, statins, chemoprevention, esophageal adenocarcinoma, high-grade dysplasia, neoplasia risk, medication use
- MeSH terms
- Aged, Anti-Inflammatory Agents, Non-Steroidal, Barrett Esophagus, Esophageal Neoplasms, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Drug Monitoring, Proton Pump Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
